US Stock MarketDetailed Quotes
MGRX Mangoceuticals
- 2.485
- -0.005-0.20%
Close Jan 3 16:00 ET
- 2.510
- +0.025+1.01%
Post 17:41 ET
6.18MMarket Cap-0.57P/E (TTM)
2.570High2.450Low26.91KVolume2.490Open2.490Pre Close67.34KTurnover1.55%Turnover RatioLossP/E (Static)2.49MShares16.80052wk High0.46P/B4.32MFloat Cap2.07052wk Low--Dividend TTM1.74MShs Float65.550Historical High--Div YieldTTM4.82%Amplitude2.070Historical Low2.502Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Mangoceuticals Stock Forum
For this kind of stocks, no news = good news.
20/12/2024 - 06:33
Dallas, TX, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, today announced the acquisition of patent number WO 2023/086647 PCT/US2022/049857, for mushroom-derived compositions and me...
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Aadi Biosciences (AADI.US)$ PR AH 12/...
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
Positive
Acquisition of patent for mushroom-derived compositions expands intellectual property portfolio
Entry into fast-growing functional mushroom market valued at $32.41 billion
Market projected to grow to $48.59 billion by 2029 with 8.44% CAGR
Negative
None.
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
Thursday, 19th December at 5:33 pm
Dallas, TX, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness products via a secure telemedicine platform, today announced the acquisition of patent number WO 2023/086647 PCT/US2022/049857, for mushroom-derived...
7 MINUTES AGO, 7:00 AM EST
VIA GLOBENEWSWIRE
DALLAS, TX, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness products via a secure telemedicine platform, today announced that it has launched an investigati...
No comment yet